Impairments in vision, even if they don’t cause autism, are likely to be manifestations of underlying neural abnormalities, says Pawan Sinha, professor of vision and founder of the humanitarian organization Project Prakash.  

A compound that shows promise as a treatment for fragile X syndrome alleviates repetitive behaviors in mice, but unexpectedly makes them less social.

Zebrafish share genes and pathways with humans, making them a useful tool to identify the genes that malfunction in autism, says expert Hazel Sive.

Screening for metabolic disorders in children with autism is not cost-effective, according to a study published 7 July in PLoS One. The researchers argue instead for careful individual clinical analysis.

A complicated interplay between a certain genetic variant and autism, schizophrenia and rheumatoid arthritis adds one more intriguing correlation to the growing list of autism risk factors.

Genetic variants in two autism-associated genes have been linked to repetitive behavior and hyperactivity, two common symptoms of the disorder, according to two studies published in the past few months.

Giving GLYX-13, a drug that targets an autism-associated brain pathway, to rats bred to be less social increases how much they communicate while playing.

At a workshop where some of the top scientists in autism research assembled to discuss biomarkers, a 7-year-old girl with the disorder was the real expert.

Neurofeedback studies showing improvement in symptoms in people with autism are deeply flawed, according to a new review.

An ingenious new technique may allow small brain implants to release chemicals when and where they are needed, according to a study published 2 June in the Journal of Neural Engineering.